Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02814227 · ClinicalTrials.gov registry record · NA
Validation of Sleep Apnea Screening Device
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 52
- Enrollment target
NCT02814227 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 52 participants.
The verdict
NCT02814227, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 52 participants
- Enrollment target
Study Summary
Obstructive sleep apnea (OSA) is the most common type of sleep apnea. OSA affects an estimated 18-40 million adults and 0.7-3% of all children in the US. The marketplace currently does not have an affordable, easy-to-use, over-the-counter, home-based OSA screening device. An affordable, available, FDA-approved and easy-to-use over-the-counter OSA screening tool would allow greater screening of at-risk individuals, especially in underserved communities with low socioeconomic status, hopefully encouraging a greater proportion of such individuals to seek treatment for their condition. The specific goal of this project is to compare the Zansors® micro sleep sensor screening device against gold-standard polysomnography to establish the device's preliminary validity to screen for OSA accurately.
Interventions
- DEVICE Zansors® sleep screening device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2014-09 |
| Est. Completion | 2015-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02814227
The ClinicalTrials.gov registry entry for NCT02814227 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Zansors® sleep screening device is the first listed.
NCT02814227 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02814227 about?
NCT02814227 is a clinical study titled "Validation of Sleep Apnea Screening Device". Obstructive sleep apnea (OSA) is the most common type of sleep apnea. OSA affects an estimated 18-40 million adults and 0.7-3% of all children in the US. The marketplace currently does not have an affordable, easy-to-use, over-the-counter, home-based OSA screening device. An affordable, available, F...
What is the current status of trial NCT02814227?
This trial is currently completed. It is a NA study. The enrollment target is 52 participants. The study started on 2014-09. Estimated completion is 2015-12.
What interventions are being tested in trial NCT02814227?
The interventions under investigation include: Zansors® sleep screening device (DEVICE).
Who is sponsoring clinical trial NCT02814227?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.